Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration-resistant prostate cancer

To determine the optimal number of cycles of docetaxel for metastatic castration-resistant prostate cancer, we retrospectively collected 73 patients receiving varying numbers of docetaxel plus prednisolone and analyzed the clinical outcomes including overall survival, prostate-specific antigen (PSA)...

Full description

Bibliographic Details
Main Authors: Yuan-Chi Shen, Po-Hui Chiang, Hao-Lun Luo, Yao-Chi Chuang, Yen-Ta Chen, Chih-Hsiung Kang, Chun-Chien Hsu, Wei-Ching Lee, Yuan-Tso Cheng
Format: Article
Language:English
Published: Wiley 2016-09-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X16301322